Tariq A. Khemees, MD
Previous position: Urology Resident, The Ohio State University, Columbus, OH
Dr. Khemees completed his SUO fellowship in urologic oncology at UW in 2020 and is currently on staff at OhioHealth in Columbus, OH. While at UW, Dr. Khemees published three articles as primary author and contributed to three others. He presented papers at the Society of Urologic Oncology annual meetings, the 2018 Society for Basic Urologic Research annual meeting, as well as at the American Urological Association. He won a best poster award at the SUO for his work looking at urine markers.
Shivashankar Damodaran, MD
Previous position: Assistant Professor of Urology and General Surgery in Sri Satya Sai Medical College and Research Institute
Dr. Damodaran completed his SUO fellowship in urologic oncology at UW in 2018 and is currently a urology resident at the University of Toledo. During his time at UW, he published nine manuscripts as well as several book chapters. He presented papers at both the Society of Urologic Oncology meetings, Wisconsin Urologic, as well as at the American Urological Association.
Michael Blute, MD
Wayne State University
Dr. Blute completed his SUO fellowship requirements at Wisconsin in 2016. During his time at the University of Wisconsin, he worked on basic science and clinical research projects, and he was funded by a T32 training grant. As a fellow, Dr. Blute’s work resulted in 10 first author (16 total) peer reviewed manuscripts. His manuscripts were published in high-impact journals including Journal of Clinical Oncology, Journal of Urology, and European Urology.
During the 2015 AUA, Dr. Blute presented seven abstracts at the AUA national meeting in New Orleans, LA, a new record for Wisconsin fellows. One of his presentations won a coveted best poster award for “Renin-angiotensin Inhibitors in Bladder Cancer Progression,” and a second presentation was featured in the take home points.
Clinically, Dr. Blute was exposed to broad training in minimally invasive and open surgery for complex urologic cancers including post-chemotherapy retroperitoneal lymph node dissection, cystectomy and cytoreductive nephrectomy.
Matthew Truong, MD
Western New York Medical Practice, Rochester
Dr. Matthew Troung completed a research fellowship in urologic oncology at UW followed by Urology residency training at the University of Rochester and an Oncology Fellowship at the Cleveland Clinic. Dr. Truong is currently a practicing urologist in Rochester, NY. During his time at UW, he was funded through an AUA Herbert Brendler award and a Shapiro Research Scholarship. He published 10 peer-reviewed manuscripts, five as first author including a seminal paper developing a nomogram for predicting cancer upgrading (Cancer 2014) and developing new epigenetic prostate cancer biomarkers (J Urol 2013).